Keyphrases
Prostate Cancer
100%
Long Non-coding RNA (LncRNA)
100%
Androgen Receptor
100%
Androgen Receptor Expression
100%
Enzalutamide Resistance
100%
Prostate
15%
Androgen Receptor Antagonist
15%
Enzalutamide
15%
Acquired Resistance
7%
Oligonucleotides
7%
Exon 5
7%
Negative Regulation
7%
Pharmacologic
7%
Dominant Role
7%
Small Molecule Inhibitors
7%
Prostate Cancer Cells
7%
Prostate Tumor
7%
Positive Feedback Loop
7%
Enhancer of Zeste Homolog 2 (EZH2)
7%
Significant Loss
7%
Androgen Signaling
7%
Human Prostate
7%
ACK1
7%
Cancer Cell Proliferation
7%
Castration-resistant Prostate Cancer
7%
Prostate Cells
7%
GCN5
7%
New Therapeutic Modalities
7%
Xenograft Tumor Growth
7%
TNK2
7%
Translational Relevance
7%
Histone Acetyltransferase
7%
Androgen Receptor Gene
7%
H3K14 Acetylation
7%
Medicine and Dentistry
Prostate Cancer
100%
Receptor Expression
100%
Androgen Receptor
100%
Long Untranslated RNA
100%
Enzalutamide
100%
Promoter Region
21%
Androgen Receptor Antagonist
14%
Cell Proliferation
7%
Cancer Cell
7%
Exon
7%
Cell Line
7%
Xenograft
7%
Tumor Progression
7%
Prostate Tumor
7%
Therapeutic Modality
7%
Receptor Gene
7%
Oligonucleotide
7%
Positive Feedback
7%
Prostate Cell
7%
Acetylation
7%
Histone Acetyltransferase GCN5
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen Receptor
100%
Long Untranslated RNA
100%
Enzalutamide
100%
Androgen Receptor Antagonist
14%
Tumor Growth
7%
Prostate Tumor
7%
Histone Acetyltransferase GCN5
7%
Oligonucleotide
7%